[10¿ù ÀÇ°úÇкоߺ° ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå]
Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ÀÇ°úÇкоßÀÇ ±¹³» ¹× ±¹Á¦ Àú³Î¿¡ 10¿ù¿¡ ¹ßÇ¥µÈ ³í¹®Àº ±¹³» Àú³ÎÀ» ÅëÇØ 1,685Æí, ±¹¿Ü Àú³ÎÀ» ÅëÇÑ ³í¹® 2,003ÆíÀ¸·Î ÃÑ 3,688ÆíÀÌ ¹ßÇ¥µÇ¾ú´Ù. ÀÌ´Â Àü¿ù 9¿ù ¹ßÇ¥µÈ 3,555Æí¿¡ ºñ±³ÇÏ¿© 3.91%(133Æí) °¨¼ÒÇÑ Ãß¼¼¸¦ ³ªÅ¸³»¾ú´Ù. ÀÇ°úÇÐ ºÐ¾ßº°·Î ±¹³»¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ Å°¿öµå¸¦ ±âÃÊÀÇÇÐ, ÀÓ»óÀÇÇÐ, ¿¹¹æÀÇÇÐ, Ä¡ÀÇÇÐ, °£È£ÇÐ, ÅëÇÕÀÇ°úÇÐ ºÐ¾ßÀÇ ÃֽŠÇÙ½É ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå ¹× Å°¿öµå´Â ¾Æ·¡ Ç¥¿Í °°´Ù.
±×¸² 1. ÅëÇÕ ÀÇ°úÇÐ ºÐ¾ß ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)
ÀÇ°úÇÐ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå(n=3,688)
|
Å°¿öµå ¼øÀ§
|
±¹³» ÀÇ°úÇÐ ¿¬±¸µ¿Çâ
|
±¹¿Ü ÀÇ°úÇÐ ¿¬±¸µ¿Çâ
|
ÀÇ°úÇÐ ¿¬±¸µ¿Çâ
|
1
|
Women
|
Genes
|
Risk
|
2
|
General Surgery
|
Risk
|
Genes
|
3
|
COVID-19
|
Neoplasms
|
Women
|
4
|
Risk
|
Humans
|
Neoplasms
|
5
|
Neoplasms
|
Attention
|
General Surgery
|
6
|
Pain
|
Women
|
COVID-19
|
7
|
Complication
|
Role
|
Humans
|
8
|
Genes
|
General Surgery
|
Role
|
9
|
Survival Rate
|
Economics
|
Attention
|
10
|
Education
|
Survival Rate
|
Survival Rate
|
±×¸² 2. ÀÓ»óºÐ¾ß ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)
ÀÓ»óÀÇÇÐºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=1,777)
|
Å°¿öµå ¼øÀ§
|
±¹³» ÀÓ»óÀÇÇÐ Å°¿öµå
|
±¹¿Ü ÀÓ»óÀÇÇÐ Å°¿öµå
|
ÅëÇÕÀÓ»óÀÇÇÐ Å°¿öµå
|
1
|
General Surgery
|
Risk
|
Risk
|
2
|
Women
|
General Surgery
|
General Surgery
|
3
|
Risk
|
Women
|
Women
|
4
|
Pain
|
Survival Rate
|
Survival Rate
|
5
|
Complication
|
Neoplasms
|
Complication
|
6
|
COVID-19
|
Complication
|
Neoplasms
|
7
|
Survival Rate
|
F-18 Fdg Pet
|
COVID-19
|
8
|
Neoplasms
|
Sensitivity & Specificity
|
Pain
|
9
|
Mortality
|
Mortality
|
Mortality
|
10
|
Stroke
|
Recurrence
|
Recurrence
|
±×¸² 3. ±âÃÊÀÇÇÐ ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)
±âÃÊÀÇÇÐ ºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=1,127)
|
Å°¿öµå ¼øÀ§
|
±¹³» ±âÃÊÀÇÇÐ ¿¬±¸
|
±¹¿Ü ±âÃÊÀÇÇÐ ¿¬±¸
|
ÅëÇÕ ±âÃÊÀÇÇÐ Å°¿öµå
|
1
|
Genes
|
Genes
|
Genes
|
2
|
Role
|
Humans
|
Humans
|
3
|
Neoplasms
|
Economics
|
Role
|
4
|
COVID-19
|
Neoplasms
|
Economics
|
5
|
Humans
|
Role
|
Neoplasms
|
6
|
Economics
|
Attention
|
Attention
|
7
|
Education
|
Risk
|
Drug
|
8
|
Attention
|
Drug
|
Risk
|
9
|
DNA
|
Population
|
DNA
|
10
|
Drug
|
DNA
|
COVID-19
|
±×¸² 4. ¿¹¹æÀÇÇÐ ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå( 2021³â 10¿ù)
|
¿¹¹æÀÇÇÐ/º¸°ÇÇÐ ºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=376)
|
Å°¿öµå¼øÀ§
|
±¹³» ¿¹¹æÀÇÇÐ ¿¬±¸µ¿Çâ
|
±¹¿Ü ¿¹¹æÀÇÇÐ ¿¬±¸µ¿Çâ
|
ÅëÇÕ ¿¹¹æÀÇÇÐ Å°¿öµå
|
1
|
Income
|
Attention
|
Risk
|
2
|
Women
|
Soil
|
Attention
|
3
|
COVID-19
|
Risk
|
Women
|
4
|
Risk
|
Water
|
COVID-19
|
5
|
Smoking
|
Environment
|
Environment
|
6
|
Behavior
|
COVID-19
|
Soil
|
7
|
Depression
|
Women
|
Behavior
|
8
|
Environment
|
Humans
|
Income
|
9
|
Health Care Costs
|
Pediatrics
|
Water
|
10
|
Family
|
Efficiency
|
Pediatrics
|
±×¸² 5. Ä¡ÀÇÇÐ ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)
Ä¡ÀÇÇÐ ºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=231)
|
Å°¿öµå ¼øÀ§
|
±¹³» Ä¡ÀÇÇÐ ¿¬±¸µ¿Çâ
|
±¹¿Ü Ä¡ÀÇÇÐ ¿¬±¸µ¿Çâ
|
ÅëÇÕ Ä¡ÀÇÇÐ Å°¿öµå
|
1
|
Tooth
|
Tooth
|
Tooth
|
2
|
Bone And Bones
|
General Surgery
|
Bone & Bones
|
3
|
Dental Hygienists
|
Pain
|
Pain
|
4
|
Oral Health
|
Temporomandibular Joint
|
Dental Hygienists
|
5
|
Education
|
Bone And Bones
|
Oral Health
|
6
|
Pain
|
Biofilms
|
Temporomandibular Joint
|
7
|
Women
|
Complication
|
General Surgery
|
8
|
Temporomandibular Joint
|
Recurrence
|
Education
|
9
|
Radiograph
|
Rotation
|
Women
|
10
|
Pediatrics
|
Survival Rate
|
Dental Implants
|
±×¸² 6. °£È£ÇÐ ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)
°£È£ÇÐ ºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=177)
|
Å°¿öµå ¼øÀ§
|
±¹³» °£È£ÇÐ ¿¬±¸µ¿Çâ
|
±¹¿Ü °£È£ÇÐ ¿¬±¸µ¿Çâ
|
°£È£ÇÐ ¿¬±¸µ¿Çâ
|
1
|
Education
|
Depression
|
Education
|
2
|
Behavior
|
Neoplasms
|
Depression
|
3
|
Women
|
Family
|
Women
|
4
|
Older Adults
|
COVID-19
|
Quality Of Life
|
5
|
Quality Of Life
|
Education
|
Behavior
|
6
|
Depression
|
Quality Of Life
|
Older Adults
|
7
|
Family
|
Women
|
Family
|
8
|
COVID-19
|
Cancer Survivors
|
COVID-19
|
9
|
Social Support
|
Attitude
|
Attitude
|
10
|
Aptitude
|
Evaluation Studies As Topic
|
Neoplasms
|
ÀÇ°úÇÐ ºÐ¾ßº° ³í¹® ¹ßÇ¥ÇöȲÀº ÀÓ»óÀÇÇÐ ±¹³» 1,004Æí°ú, ±¹¿Ü¹ßÇ¥ 773ÆíÀ¸·Î ÃÑ 1,778ÆíÀÌ ¹ßÇ¥µÇ¾úÀ¸¸ç ÀÌ´Â ÀÇ°úÇко߿¡¼ °¡Àå ¸¹Àº ¹ßÇ¥¼øÀ§¸¦ ³ªÅ¸³»¾ú´Ù. ±× µÚ¸¦ ÀÌ¾î ±âÃÊÀÇÇÐ 1,127ÆíÀ¸·Î ÀÌ´Â ±¹³»¹ßÇ¥°¡ 201Æí, ±¹¿Ü¹ßÇ¥ 926ÆíÀ¸·Î ³ªÅ¸³µ´Ù. ¿¹¹æÀÇÇÐ/º¸°ÇÇкоߴ ±¹³» 158Æí, ±¹¿Ü 218Æí, °£È£Çкоߴ ±¹³» 133Æí, ±¹¿ÜÀú³ÎÀ» ÅëÇØ 44ÆíÀÌ ¹ßÇ¥µÇ¾úÀ¸¸ç, Ä¡ÀÇÇÐÀº ±¹³» 189Æí, ±¹¿ÜÀú³ÎÀ» ÅëÇØ 42ÆíÀÌ ¹ßÇ¥µÇ¾ú´Ù. ƯÈ÷ Ä¡ÀÇÇкоßÀÇ ±¹³»¿Ü Àú³ÎÀ» ÅëÇÑ ³í¹®¹ßÇ¥´Â Àü¿ù 9¿ù¿¡ ¹ßÇ¥µÈ 79°Ç¿¡ ºñ±³ÇÏ¿© 92.4%°¡ Áõ°¡µÈ 231ÆíÀÌ 10¿ù¿¡ ¹ßÇ¥µÇ¾ú´Ù. ÀÇ°úÇкоߺ° ³í¹®µ¥ÀÌÅÍ ÃßÃâÀ» À§ÇØ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿Í PubMed DB¿¡ À妽ºµÈ ³í¹®µ¥ÀÌÅ͸¦ ÃßÃ⠺м®ÇÏ¿´´Ù.
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø
* º» ³»¿ëÀº MedRIC (www.medric.or.kr)ÀÇ ¿¬±¸µ¿Çâ¿¡¼ ¼ºñ½ºµÇ´Â ³»¿ëÀÔ´Ï´Ù.